Applied BioCode Corporation (6598.TW)
TWD 20.35
(-0.97%)
TWD 20.35
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 395.16 Million | 390.3 Million | 319.96 Million | 299.01 Million | 104.69 Million | 37.14 Million |
| Cost of Revenue | 126.43 Million | 156.13 Million | 130.59 Million | 105.49 Million | 51.72 Million | 20.41 Million |
| Gross Profit | 268.73 Million | 234.17 Million | 189.36 Million | 193.52 Million | 52.96 Million | 16.73 Million |
| Operating Expenses | 455.44 Million | 426.77 Million | 354.31 Million | 327.03 Million | 328.04 Million | 284.61 Million |
| Selling, General and Administrative Expenses | 209.43 Million | 188.4 Million | 148.45 Million | 130.03 Million | 111.06 Million | 88.9 Million |
| Research and Development Expenses | 246 Million | 238.37 Million | 205.85 Million | 197 Million | 216.97 Million | 195.7 Million |
| Other Expenses | - | 2.16 Million | -474 Thousand | 30.62 Million | 1.61 Million | 251 Thousand |
| Cost and Expenses | 581.87 Million | 582.9 Million | 484.9 Million | 432.52 Million | 379.76 Million | 305.02 Million |
| Operating Income | -186.7 Million | -181.92 Million | -162.3 Million | -99.15 Million | -273.46 Million | -267.62 Million |
| Interest Expense | 2.16 Million | 2.78 Million | 2.87 Million | 4.31 Million | 6.58 Million | 653 Thousand |
| Income Tax Expense | 758 Thousand | 23 Thousand | 23 Thousand | 24 Thousand | 24 Thousand | 24 Thousand |
| Earnings before Tax | -163.44 Million | -184.71 Million | -165.17 Million | -103.47 Million | -280.04 Million | -268.28 Million |
| Net Income | -164.19 Million | -184.73 Million | -165.19 Million | -103.49 Million | -280.07 Million | -268.3 Million |
| Earnings Per Share Basic | -2.01 | -2.26 | -2.02 | -1.33 | -4.36 | -5.06 |
| Earnings Per Share Diluted | -2.01 | -2.26 | -2.02 | -1.33 | -4.36 | -5.06 |
| Weighted Average Shares Outstanding | 81.76 Million | 81.75 Million | 81.7 Million | 77.57 Million | 64.27 Million | 52.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.76 Million | 81.75 Million | 81.7 Million | 77.57 Million | 64.27 Million | 52.98 Million |
| Gross Margin | 0.68 | 0.60 | 0.59 | 0.65 | 0.51 | 0.45 |
| EBIT Margin | -0.25 | -0.32 | -0.35 | -0.19 | -2.30 | -6.76 |
| Profit Margin | -0.42 | -0.47 | -0.52 | -0.35 | -2.68 | -7.22 |
| EBITDA | -98.59 Million | -125.41 Million | -111.34 Million | -55.56 Million | -240.65 Million | -250.99 Million |
| Earnings Before Tax Margin | -0.47 | -0.47 | -0.51 | -0.33 | -2.61 | -7.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 101.63 Million | 81.5 Million | 395.16 Million | 128.22 Million | 105.75 Million | 78.47 Million |
| Cost of Revenue | 51.18 Million | 40.49 Million | 171.63 Million | 36.65 Million | 34.41 Million | 37.39 Million |
| Gross Profit | 50.44 Million | 41 Million | 223.53 Million | 91.57 Million | 71.34 Million | 41.08 Million |
| Operating Expenses | 106.25 Million | 110.24 Million | 410.23 Million | 106.66 Million | 120.78 Million | 108.44 Million |
| Selling, General and Administrative Expenses | 40.93 Million | 40.08 Million | - | 36.87 Million | 60.15 Million | 50.88 Million |
| Research and Development Expenses | 65.31 Million | 70.16 Million | - | 69.79 Million | 60.63 Million | 57.55 Million |
| Other Expenses | 353 Thousand | 679 Thousand | 1.46 Million | 1.12 Million | 278 Thousand | 493 Thousand |
| Cost and Expenses | 157.44 Million | 150.74 Million | 581.87 Million | 143.31 Million | 155.19 Million | 145.84 Million |
| Operating Income | -55.8 Million | -69.23 Million | -186.7 Million | -15.09 Million | -42.98 Million | -60.49 Million |
| Interest Expense | 387 Thousand | 427 Thousand | 2.16 Million | 482 Thousand | 533 Thousand | 554 Thousand |
| Income Tax Expense | 25 Thousand | -1.00 | 758 Thousand | 6000.00 | 9000.00 | 28 Thousand |
| Earnings before Tax | -49.98 Million | -63.12 Million | -163.44 Million | -8.57 Million | -43.72 Million | -61.13 Million |
| Net Income | -50 Million | -63.12 Million | -164.19 Million | -8.57 Million | -43.73 Million | -61.16 Million |
| Earnings Per Share Basic | -0.58 | -0.77 | - | -0.10 | -0.53 | -0.75 |
| Earnings Per Share Diluted | -0.58 | -0.77 | - | -0.10 | -0.53 | -0.75 |
| Weighted Average Shares Outstanding | 86.53 Million | 81.77 Million | 81.76 Million | 81.76 Million | 81.76 Million | 81.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.53 Million | 81.77 Million | 81.76 Million | 81.76 Million | 81.76 Million | 81.76 Million |
| Gross Margin | 0.50 | 0.50 | 0.57 | 0.71 | 0.67 | 0.52 |
| EBIT Margin | -0.40 | -0.66 | - | 0.01 | -0.25 | -0.57 |
| Profit Margin | -0.49 | -0.77 | -0.42 | -0.07 | -0.41 | -0.78 |
| EBITDA | -40.47 Million | -53.78 Million | - | 976 Thousand | -26.93 Million | -44.91 Million |
| Earnings Before Tax Margin | -0.55 | -0.85 | -0.47 | -0.12 | -0.41 | -0.77 |
CRH
BFT
2428
5347
VALUE
HSTXF